NURIX THERAPEUTICS INC
NRIX · NASDAQ
Updated at 2026-10-15 09:31:54
- Today's High
- $24.01
- Today’s Low
- $21.40
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $22.01
- Previous Close
- $23.67
- Volume
- 3.82M
- Market Cap
- $2.45B
- P/E Ratio
- --
- EPS
- $-3.44
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1600 SIERRA POINT PARKWAY, BRISBANE, CA, UNITED STATES, 94005
- Country
- US
- Listing Date
- 2020-07-24
- Fiscal Year End
- November
- Shares Outstanding
- 103.78M
- CIK
- 0001549595
- Website
- www.nurixtx.com
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company is headquartered in San Francisco, California.
Financial Metrics
Revenue
2026-05-31
$9.04M
2026-02-28
$6.25M
2025-11-30
$13.57M
2025-08-31
$7.89M
Operating Expenses
2026-05-31
$99.39M
2026-02-28
$14.61M
2025-11-30
$92.04M
2025-08-31
$94.27M
Net Income
2026-05-31
-$89.53M
2026-02-28
-$87.17M
2025-11-30
-$78.22M
2025-08-31
-$86.42M
Net Profit Margin
2026-05-31
-990.1%
2026-02-28
-1.39K%
2025-11-30
-576.12%
2025-08-31
-1.09K%
Earnings Per Share
2026-05-31
$-0.81
2026-02-28
$-0.79
2025-11-30
$-0.82
2025-08-31
$-1.03
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-05-31
-$85.95M
2026-02-28
-$83.39M
2025-11-30
-$73.59M
2025-08-31
-$81.42M
Effective Tax Rate
2026-05-31
0.3%
2026-02-28
--
2025-11-30
--
2025-08-31
--
| Item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 |
|---|---|---|---|---|
| Revenue | $9.04M | $6.25M | $13.57M | $7.89M |
| Operating Expenses | $99.39M | $14.61M | $92.04M | $94.27M |
| Net Income | -$89.53M | -$87.17M | -$78.22M | -$86.42M |
| Net Profit Margin | -990.1% | -1.39K% | -576.12% | -1.09K% |
| Earnings Per Share | $-0.81 | $-0.79 | $-0.82 | $-1.03 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$85.95M | -$83.39M | -$73.59M | -$81.42M |
| Effective Tax Rate | 0.3% | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.